• Join
  • Login
  • Contact

Search abstracts

Effects of Thiazolidinediones on development of macrovascular complications in type 2 Diabetes Mellitus

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Poster
  • By: SERDAREVIC, Lejla (Pharmacy Avicena, Visoko, Bosnia and Herzegovina)
  • Co-author(s): Semiz Sabina, S. (University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina)
  • Abstract:

    Type 2 diabetes mellitus (T2DM) is a chronic, metabolic disorder with an increased risk for developing macrovascular complications. In addition to life style modifications, different oral hypoglycemic agents are used to achieve optimal glycemic control in Type 2 diabetic patients. Thiazolidinediones (TZD's), pioglitazone and rosiglitazone, are


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses